Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronos: Duloxetine plus chronotherapy in major depression
2005-001855-39Phase 4Completed
- Sponsor
- Psychiatric Research Unit, Region Zealand
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of duloxetine in major depressive disorder (MDD), sponsored by Psychiatric Research Unit, Region Zealand. Primary endpoint: Remission and response rates at study completion. Started Jun 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-001855-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001855-39.